Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer

Research output: Contribution to journalArticlepeer-review

Abstract

In today's complex healthcare landscape, the pursuit of delivering optimal patient care while navigating intricate economic dynamics poses a significant challenge for healthcare service providers (HSPs). In this already complex dynamic, the emergence of clinically promising personalized medicine-based treatment aims to revolutionize medicine. While personalized medicine holds tremendous potential for enhancing therapeutic outcomes, its integration within resource-constrained HSPs presents formidable challenges. In this study, we investigate the economic feasibility of implementing personalized medicine. The central objective is to strike a balance between catering to individual patient needs and making economically viable decisions. Unlike conventional binary approaches to personalized treatment, we propose a more nuanced perspective by treating personalization as a spectrum. This approach allows for greater flexibility in decision-making and resource allocation. To this end, we propose a mathematical framework to investigate our proposal, focusing on Bladder Cancer (BC) as a case study. Our results show that while it is feasible to introduce personalized medicine, a highly efficient but highly expensive one would be short-lived relative to its less effective but cheaper alternative as the latter can be provided to a larger cohort of patients, optimizing the HSP's objective better.

Original languageEnglish
Article number1388685
JournalFrontiers in Medicine
Volume11
DOIs
StatePublished - 2024

Keywords

  • healthcare economics
  • healthcare systems management
  • patient-centric care
  • personalized medicine
  • resource-constrained healthcare

Fingerprint

Dive into the research topics of 'Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer'. Together they form a unique fingerprint.

Cite this